We’re excited to share that our work in #RadiopharmaceuticalTherapy has been featured in a recent Handelsblatt article, highlighted in the Insight #Innovation category. Maike Telgheder provides valuable insights into how #radiopharmaceutical therapy is advancing treatment options for prostate cancer, a cause we're deeply committed to. We were pleased to host Ms. Telgheder at our NOVA facility in Neufahrn earlier this summer. We appreciate the opportunity to showcase our production processes and discuss our contributions to this growing industry. 📰 Read the full article in the latest print edition of Handelsblatt or on the online portal.
Hagen Hultzsch
2mo
Wertvolle Hochtechnologie 👍
Congratulations ITM!
Daniela Tosch
2mo
Congrats, what an amazing success
Chairman Of The Board bei Vetter Pharma
2moWhat a strong ticket for patients in this indications Better answers then may be 👍👍👍 Udo j Vetter itm chair 🪑